Project Details
| Status | Active |
|---|---|
| Effective start/end date | 01/30/24 → 08/28/26 |
Funding
- Biohaven Pharmaceuticals Holding Company Ltd.: $35,399.80
A Phase 2/3 Multicenter, Randomized, Double-Blind,Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of Adjunctive Treatment with BHV-7000 in Subjects with Focal Onset Epilepsy
- Spiegel, Rebecca (PI)
- Cruz, Elizabeth (CoPI)
- Krutoshinskaya, Yana (CoPI)
- Leone, Bridget (CoPI)
- Pushchinska, Galyna (CoPI)
Project: Research